Unsealed FCA Suit Accuses Pfizer Of Off-Label Marketing
By Erin Coe · November 29, 2011, 10:40 PM EST
A federal court on Tuesday unsealed two ex-Pfizer Inc. employees' qui tam suit alleging the drugmaker marketed anti-fungal medication Vfend for off-label use that put patients at risk and caused the...
To view the full article, register now.